BRIEF-Endocyte Q4 loss per share $0.26
March 10, 2017 at 08:24 AM EST
* Endocyte reports fourth quarter and year end 2016 financial results and provides clinical and pipeline update
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|